Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Butyrate Regulates COVID-19-Relevant Genes in Gut Epithelial Organoids From Normotensive Rats.

Literature DB >> 33439735

Butyrate Regulates COVID-19-Relevant Genes in Gut Epithelial Organoids From Normotensive Rats.

Jing Li¹, Elaine M Richards¹, Eileen M Handberg², Carl J Pepine², Mohan K Raizada¹.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2020 PMID： 33439735 PMCID： PMC7810239 DOI： 10.1161/HYPERTENSIONAHA.120.16647

Source DB: PubMed Journal: Hypertension ISSN： 0194-911X Impact factor: 10.190

× No keyword cloud information.

5 in total

Review 1. ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.

Authors: Ravindra K Sharma; Bruce R Stevens; Alexander G Obukhov; Maria B Grant; Gavin Y Oudit; Qiuhong Li; Elaine M Richards; Carl J Pepine; Mohan K Raizada
Journal: Hypertension Date: 2020-08-12 Impact factor: 10.190

2. SARS-CoV-2 Receptor ACE2 (Angiotensin-Converting Enzyme 2) Is Upregulated in Colonic Organoids From Hypertensive Rats.

Authors: Jing Li; Bruce R Stevens; Elaine M Richards; Mohan K Raizada
Journal: Hypertension Date: 2020-07-09 Impact factor: 10.190

3. Targeting innate immunity by blocking CD14: Novel approach to control inflammation and organ dysfunction in COVID-19 illness.

Authors: Thomas R Martin; Mark M Wurfel; Ivan Zanoni; Richard Ulevitch
Journal: EBioMedicine Date: 2020-06-20 Impact factor: 8.143

4. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.

Authors: Daniel Blanco-Melo; Benjamin E Nilsson-Payant; Wen-Chun Liu; Skyler Uhl; Daisy Hoagland; Rasmus Møller; Tristan X Jordan; Kohei Oishi; Maryline Panis; David Sachs; Taia T Wang; Robert E Schwartz; Jean K Lim; Randy A Albrecht; Benjamin R tenOever
Journal: Cell Date: 2020-05-15 Impact factor: 41.582

5. MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses.

Authors: Anna Bruchez; Ky Sha; Joshua Johnson; Li Chen; Caroline Stefani; Hannah McConnell; Lea Gaucherand; Rachel Prins; Kenneth A Matreyek; Adam J Hume; Elke Mühlberger; Emmett V Schmidt; Gene G Olinger; Lynda M Stuart; Adam Lacy-Hulbert
Journal: Science Date: 2020-08-27 Impact factor: 47.728

5 in total

9 in total

1. Association of Increased Circulating Acetic Acid With Poor Survival in Pseudomonas aeruginosa Ventilator-Associated Pneumonia Patients.

Authors: Xiaoling Qi; Li Zhang; Jing Xu; Zheying Tao; Xiaoli Wang; Yuzhen Qiu; Tingting Pan; Zhaojun Liu; Hongping Qu; Ruoming Tan; Jialin Liu
Journal: Front Cell Infect Microbiol Date: 2021-04-29 Impact factor: 5.293

Review 2. Tryptophan Metabolites and Aryl Hydrocarbon Receptor in Severe Acute Respiratory Syndrome, Coronavirus-2 (SARS-CoV-2) Pathophysiology.

Authors: George Anderson; Annalucia Carbone; Gianluigi Mazzoccoli
Journal: Int J Mol Sci Date: 2021-02-05 Impact factor: 5.923

3. Hypertension Update: A Reflection of the Past Decade.

Authors: Anna F Dominiczak; Trudie J Meyer
Journal: Hypertension Date: 2021-11-10 Impact factor: 10.190

4. A New Butyrate Releaser Exerts a Protective Action against SARS-CoV-2 Infection in Human Intestine.

Authors: Lorella Paparo; Maria Antonia Maglio; Maddalena Cortese; Cristina Bruno; Mario Capasso; Erika Punzo; Veronica Ferrucci; Vito Alessandro Lasorsa; Maurizio Viscardi; Giovanna Fusco; Pellegrino Cerino; Alessia Romano; Riccardo Troncone; Massimo Zollo
Journal: Molecules Date: 2022-01-27 Impact factor: 4.411

Butyrate Regulates COVID-19-Relevant Genes in Gut Epithelial Organoids From Normotensive Rats.

Review 1. ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.

2. SARS-CoV-2 Receptor ACE2 (Angiotensin-Converting Enzyme 2) Is Upregulated in Colonic Organoids From Hypertensive Rats.

3. Targeting innate immunity by blocking CD14: Novel approach to control inflammation and organ dysfunction in COVID-19 illness.

4. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.

5. MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses.

1. Association of Increased Circulating Acetic Acid With Poor Survival in Pseudomonas aeruginosa Ventilator-Associated Pneumonia Patients.

Review 2. Tryptophan Metabolites and Aryl Hydrocarbon Receptor in Severe Acute Respiratory Syndrome, Coronavirus-2 (SARS-CoV-2) Pathophysiology.

3. Hypertension Update: A Reflection of the Past Decade.

4. A New Butyrate Releaser Exerts a Protective Action against SARS-CoV-2 Infection in Human Intestine.

Review 5. Probiotics: A gut response to the COVID-19 pandemic but what does the evidence show?

Review 6. Microbiota and COVID-19: Long-term and complex influencing factors.

Review 7. Is butyrate a natural alternative to dexamethasone in the management of CoVID-19?

Review 8. Silent hypoxia in COVID-19: a gut microbiota connection.

9. Interplay between Inflammaging, Frailty and Nutrition in Covid-19: Preventive and Adjuvant Treatment Perspectives.